Previous Close | 75.94 |
Open | 76.89 |
Bid | 82.01 x 1300 |
Ask | 82.08 x 900 |
Day's Range | 73.89 - 77.15 |
52 Week Range | 36.42 - 99.63 |
Volume | |
Avg. Volume | 589,365 |
Market Cap | 2.426B |
Beta (5Y Monthly) | 2.00 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.77 |
Earnings Date | Apr 29, 2024 - May 03, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 100.50 |
Subscribe to Yahoo Finance Plus to view Fair Value for TMDX
We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.
TransMedics Group Inc (NASDAQ:TMDX) CFO Stephen Gordon sold 15,000 shares of the company's stock on March 4, 2024, according to a recent SEC filing.
In this article, we will take a detailed look at Jim Cramer’s Latest Lightning Round: 11 Stock Recommendations. For a quick overview of such stocks, read our article Jim Cramer’s Latest Lightning Round: 5 Stock Recommendations. Jim Cramer yet again grilled market naysayers in his latest program on CNBC, calling them “non-believers” who he believes only got encouraged […]